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Since excessive epidermal hyaluronan is associated with hyperproliferative states and disturbed terminal differ-
entiation of the keratinocytes, we hypothesized that 4-methylumbelliferone (4-MU), an inhibitor of hyaluronan
synthesis, could counteract these phenotypic features. Cultured epidermal keratinocytes showed a concentration
dependent, maximum 83% reduction of hyaluronan in the presence of 0.2–1.0 mM 4-MU, whereas less decline was
seen in the synthesis of chondroitin and heparan sulfate. The reduced hyaluronan was associated with no apparent
change in its molecular mass. The 4-MU-treated keratinocytes showed an accentuated epithelial morphology with a
ﬂat, round cell shape, increased stress ﬁbers and large vinculin-positive adhesion plaques, cytoskeletal changes
consistent with the markedly reduced migration rate observed in scratched monolayer cultures. High concentra-
tions of 4-MU also caused a block in keratinocyte proliferation, reversible upon 4-MU withdrawal. In the epidermis
of organotypic cultures, 4-MU prevented the hyaluronan accumulation and epidermal hypertrophy induced by
epidermal growth factor. The present results concur with earlier data indicating that enhanced cell locomotion and
proliferation are associated with hyaluronan synthesis in activated keratinocytes. Cell proliferation, however, was
blocked more strongly than expected on the basis of the incomplete hyaluronan synthesis inhibition, and may
represent a novel target of 4-MU. At any rate, 4-MU and equivalent hyaluronan synthesis inhibitors might be
considered for situations where suppression of epidermal activation and hyperproliferation is warranted.
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Hyaluronan is a unique glycosaminoglycan of very high
molecular mass (up to 107 Da), synthesized directly into the
extracellular space by an enzyme (hyaluronan synthase)
associated with the cytoplasmic side of the plasma mem-
brane (Weigel et al, 1997; Tammi et al, 2002). Hyaluronan
expression is associated with tissue remodeling during
morphogenesis (Camenisch et al, 2000; Toole, 2001),
wound healing (Mack et al, 2003), and cancer (Toole,
2001), where it is supposed to facilitate cell division and
migration by creating a soft, transient matrix and by acti-
vating intracellular signaling cascades (Turley et al, 2002). A
direct role of hyaluronan in cell proliferation was supported
by the finding that transfection of Has2 gene to fibrosarco-
ma cells lead to accelerated cell proliferation and cell mi-
gration (Kosaki et al, 1999).
Hyaluronan is actively synthesized by keratinocytes and
forms a loose extracellular matrix between adjacent basal
and spinous cells of human epidermis (Tuhkanen et al,
1998). The location of hyaluronan between the vital cell
layers suggests that as a space filler it contributes to the
maintenance of the free interstitial space between keratin-
ocytes, in order to facilitate exchange of metabolites be-
tween circulation and keratinocytes, and to maintain the
plasticity of the epidermis by allowing keratinocyte move-
ments and changes of cell shape during differentiation
(Tuhkanen et al, 1998). Furthermore, hyaluronan synthesis
creates signals that control migration and proliferation of
epidermal keratinocytes (Rilla et al, 2002). A hyperprolifer-
ative and migrating phenotype is typical of epidermal ac-
tivation. Activation occurs after epidermal injury and is
common in many diseases involving epidermis, psoriasis as
an example (Nickoloff and Turka, 1993; Tomic-Canic et al,
1998). Accordingly, the proliferation rate and thickness of
epidermis, regulated by growth factors like EGF (Pienima¨ki
et al, 2001; Pasonen-Seppa¨nen et al, 2003), KGF (Karvinen
et al, 2003), and TGFb (Pasonen-Seppa¨nen et al, 2003), is
closely correlated with the synthesis of hyaluronan by ker-
atinocytes. The tight association of keratinocyte hyaluronan
synthesis to epidermal activation implies that inhibition of
hyaluronan synthesis might suppress these phenotypic fea-
tures, and modify epidermal differentiation.
The coumarine derivative 4-methylumbelliferone (4-MU)
has been reported to specifically inhibit hyaluronan synthe-
sis in cultured mammalian cells (Nakamura et al, 1995,
1997; Kosaki et al, 1999; Sohara et al, 2001). Although the
same compound has been in clinical use as a spasmolytic
Abbreviations: bHABC, biotinylated hyaluronan binding complex;
EGF, epidermal growth factor; HABC, hyaluronan binding complex;
KGF, Keratinocyte growth factor; 4-MU, 4-methylumbelliferone;
REK, rat epidermal keratinocyte; TGF-b, transforming growth
factor beta
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drug (Stacchino et al, 1983), as far as we know, its effects
on skin or skin diseases has not been studied. In this work,
we show that the inhibition of hyaluronan synthesis by 4-
MU in epidermal keratinocytes was associated with low
cell proliferation, and cytoskeletal changes consistent with
markedly reduced migratory activity. Interestingly, the sup-
pression by 4-MU was more potent in a hyperproliferative
epidermis created by epidermal growth factor, suggesting
that it might be useful in normalizing such conditions. The
data stress the importance of hyaluronan synthesis in ep-
idermal activation.
Results
4-MU inhibits hyaluronan synthesis and its EGF-in-
duced stimulation in keratinocyte cultures In the stand-
ard culture medium with 5% fetal bovine serum (FBS),
slightly preconfluent rat epidermal keratinocyte (REK) cul-
tures secreted approximately 4 ng of hyaluronan per 10,000
cells in 24 h, as measured by the ELSA assay. A concen-
tration-dependent decrease in the amount of secreted
hyaluronan was found with 0.2–1.0 mM concentrations of
4-MU (Fig 1A, C). With 0.2 mM 4-MU the relative inhibition
was  20%, whereas at 1 mM concentration the relative
inhibition was  35% and  60% after treatments of 6 and
24 h, respectively (Fig 1A, C).
A concentration-dependent decrease in the total amount
of hyaluronan synthesized in the culture (medium and cell
layer combined) was also found using quantitative meta-
bolic labeling (Table I). Furthermore, it appeared that the
synthesis of hyaluronan was more sensitive to 4-MU than
the synthesis of sulfated glycosaminoglycans (Table I).
Thus, 0.2 mM 4-MU had little effect on chondroitin sulfate
(CS) or heparan sulfate synthesis. At 0.5 mM and 1 mM of 4-
MU the synthesis of heparan sulfate was also decreased,
but less than that of hyaluronan, whereas no constant effect
was seen in CS (Table I).
Hyaluronan synthesis is strongly induced in keratinocytes
by effectors like EGF (Pienima¨ki et al, 2001; Pasonen-
Seppa¨nen et al, 2003) and KGF (Karvinen et al, 2003). As
compared to its effects on non-stimulated cells (Fig 1A, C),
4-MU caused a relatively more prominent, 65–85% inhibi-
tion in cells treated with EGF (Fig 1B, D), i.e., 4-MU was
particularly effective in inhibiting the hyaluronan synthesis in
activated keratinocytes.
A 6 h treatment with 4-MU did not change the molecular
mass distribution of the secreted hyaluronan (Fig 1E) or that
associated with the cell layer (data not shown), when analy-
zed with gel filtration.
Hyaluronan localization in REK is changed by 4-MU In
control cultures, hyaluronan visualized with the biotinylated
hyaluronan binding complex (bHABC) probe was typically
localized as dense patches (Fig 2A), mostly on the dorsal
cell surfaces, and frequently colocalized with CD44 (Fig 2C)
(Tammi et al, 1998), whereas the ventral surface showed a
lower hyaluronan signal, except close to the edge of the
lamellipodia (Fig 2E). Hyaluronan in 4-MU-treated cells had
a generally lower staining intensity, and it was more diffusely
distributed (Fig 2B). Moreover, the remaining hyaluronan in
the 4-MU-treated REK was mostly on the underside of the
cells (Fig 2D), often surrounded by a circle of adhesion
plaques (Fig 2F).
Cytoskeletal rearrangements in 4-MU-treated REK In
subconfluent REK cells, the lamellipodia usually present in
control cultures were largely lost by 4-MU-treatment, and
the cells became flat and circular (Fig 2B, D, F, H). These
changes in cell shape started already after 1 h in 1 mM 4-
MU when monitored by phase contrast microscopy of live
cells (data not shown). In control cells, phalloidin staining
visualized filamentous actin in the cell cortex and in numer-
ous filopodia (Fig 2G), whereas the filopodia were severely
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Figure1
Effect of 4-MU on hyaluronan secreted in the growth medium of
epidermal keratinocytes. Subconfluent REK cultures were subjected
to the indicated concentrations of 4-MU for 6 h (A, B) and 24 h (C, D),
with (B, D) and without 20 ng per mL of EGF (A, C), and the media were
analyzed for hyaluronan concentration using the ELSA assays. The
data represent means and ranges of two independent experiments.
The molecular mass distribution of metabolically labeled hyaluronan
secreted into the culture medium during 6 h incubations with different
concentrations of 4-MU was analyzed with gel filtration on a 1  30 cm
column of Sephacryl S-1000 (E).
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depleted in 4-MU-treated REK. Instead, stress fibers, very
rare in control cultures, appeared after a 6 h treatment with
4-MU, often forming a spindle-like structure in the middle of
the cell (Fig 2H). The cytoskeletal changes induced by 4-MU
included an increased number and size of adhesion plaques
under the cells, as demonstrated by confocal microscopy of
an immunohistochemical staining for vinculin (Fig 2E, F).
The circular arrangement of the vinculin-positive adhesion
plaques (Fig 2H) appeared to fix the cell periphery to the
substratum and was correlated with a truncation of lamelli-
podia and filopodia. In addition, microscopic assays
showed that all EGF-induced features in the REK pheno-
type (Pienima¨ki et al, 2001), including accumulation of cell
surface hyaluronan, and the lifted, elongated cell shape,
were efficiently blocked by 4-MU (data not shown).
4-MU inhibits REK cell migration Removing cells by
scratching with a pipette tip from the bottom of the dish
induces rapid migration of the REK, completely covering the
cleared area in less than 2 d. In the presence of 0.1 mM
4-MU, a 25% reduction in the migration was found in a 24 h
follow up, whereas 0.5 mM 4-MU produced 60% inhibition
(Fig 3A). The inhibition was obvious already after 3 h (Fig
3B), excluding the possible contribution of cell proliferation
in filling the cleared area.
High molecular weight hyaluronan added to the culture
medium caused 10% increase of the migration rate in
both control and 4-MU-treated cultures (data not shown),
indicating that 4-MU does not block the relatively small mi-
gration stimulation shown previously to occur in REK by
exogenous, soluble hyaluronan (Rilla et al, 2002).
4-MU inhibits cell proliferation Control REK doubled their
numbers approximately every 20 h until confluency slowed
down the proliferation. Treatment with 0.2 mM 4-MU re-
duced the number of cells by 50% on the third day in culture,
whereas with 0.5 mM dose, cell proliferation was completely
arrested (Fig 3C). The cells were also counted 4 h after plat-
ing, resulting in equal numbers for control and 4-MU-treated
cultures, which indicates that 4-MU does not disturb cell
attachment to substratum. The number of dead, floating
cells (on average 2.4% of those bound) was also similar to
that in control cultures (data not shown). Addition of high
molecular weight hyaluronan (100 mg per mL) did not change
the proliferation rate of 4-MU-treated cells (data not shown).
We also tested the reversibility of the proliferation block by
removing 4-MU from cultures after a 24 h treatment. The
effect of 4-MU on cell proliferation was fully reversible (Fig 3D)
the cell number being duplicated 24 h after 4-MU removal.
EGF-induced hyaluronan accumulation and epidermal
thickening are inhibited by 4-MU in organotypic epider-
mal cultures The REK cells stratify and differentiate into
Table I. REK cultures were metabolically labeled with 3H-glu-
cosamine and 35S-sulfate for 6 h, and the glycosaminoglycans
synthesized were analyzed using Superdex Peptide chroma-
tography
4-MU concentration
(mM)
Glycosaminoglycan (ng per 10,000 cells)
HA CS HS
0 1.08  0.04 0.38  0.21 5.82  2.27
0.2 0.46  0.09 0.54  0.37 5.13  2.15
0.5 0.29  0.03 0.49  0.33 3.59  0.83
1 0.19  0.01 0.46  0.34 1.87  0.21
The data represent the total amounts of glycosaminoglycans synthe-
sized in the cultures (cellsþmedium), expressed as means and ranges
from two independent experiments.
REK, rat epidermal keratinocyte; 4-MU, 4-methylumbelliferone; HA,
hyaluronan; CS, chondroitin sulfate; HS, heparan sulfate.
Figure2
Distribution of cell-associated hyaluronan, CD44, actin, and
vinculin in 4-MU-treated REK cells. Preconfluent cultures incubated
in 0.5 mM of 4-MU for 24 h and stained with bHABC (B, D, F) were
compared with controls (A, C, E) to illustrate the changed localization of
hyaluronan. The vertical sections of single cells obtained by deconvo-
lution of a stack of horizontal confocal sections (C, D) show the local-
ization of CD44 (red) and hyaluronan (green) on the apical plasma
membrane in controls (C), and the shift of hyaluronan to the ventral side
in 4-MU-treated cells (D). The plate bottom is shown by the white
dashed line. The arrows point the predominant localization of
hyaluronan in the cells. Panels (E, F) demonstrate the increased quan-
tity and changed distribution of vinculin-positive adhesion plaques (red)
in the undersurface of cells cultured with 4-MU. Hyaluronan (green)
resides under the central part of the 4-MU treated cells, surrounded by
a belt of adhesion plaques. Panel (H) demonstrates the loss of phal-
loidin -positive filopodia, present in control cells (G, arrow) and reor-
ganization of actin into stress fibers in the 4-MU-treated cells (H). Scale
bars¼ 20 mm (A–D) and 10 mm (E–H).
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structurally normal epidermis when cultured on a collagen
gel in the air–liquid interphase (Tammi et al, 2000; Pasonen-
Seppa¨nen et al, 2001), allowing prediction of pharmacolog-
ical impacts on epidermis in vivo. In the organotypic cul-
tures, the effect of 4-MU on the hyaluronan deposited in the
control tissue (Fig 4A) or that secreted into culture medium
(Fig 4B) was relatively small. Importantly, 4-MU did not af-
fect the normal structure or differentiation pattern of control
cultures (Fig 4A).
As shown previously (Pasonen-Seppa¨nen et al, 2003),
EGF causes a dramatic increase in epidermal hyaluronan,
increases proliferation, and interferes with the normal tissue
structure. 4-MU blocked the EGF-induced hyaluronan syn-
thesis and accumulation in the epidermis (Fig 4A, B). Fur-
thermore, 4-MU normalized the epidermal thickness and
tissue architecture disturbed by EGF (Fig 4A, C).
Discussion
This study shows that 4-MU causes a marked inhibition
of hyaluronan production in epidermal keratinocytes and
that the inhibition is particularly effective in the epidermis
activated by EGF. The decline in hyaluronan synthesis is
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Figure 3
The effect of 4-MU on proliferation and scratch-induced migration.
Cells in REK cultures were scratched off from standardized areas with a
pipette tip, the cleared area recorded by videomicroscopy, the cultures
incubated in the presence of 0–0.5 mM of 4-MU, and recorded again to
calculate the average migration rate of the cell front. Panel (A) shows
the migration rate as a function of 4-MU concentration during a 24-h
period (means  SE of five experiments with eight wounds in each,
po 0.05 and po0.01 as compared with control, paired t test). Panel
(B) shows the early time points of migration in the presence of 0.2 mM
4-MU (means and ranges of two independent cultures). For the pro-
liferation assay, equal numbers of REK cells were plated on day 0 with
the standard medium containing 0–1 mM of 4-MU. Cell numbers were
counted on the days indicated, and also 4 h after plating to determine
the plating efficiency (C). In panel (D) one set of cultures was grown
completely without 4-MU (control), another was grown in 1 mM 4-MU
for 1 d (days 1–2), then changed back to control medium, and a third
set was cultured in 1 mM 4-MU through the experiment (days 1–4). The
dashed line indicates the number of cells plated. The error bars rep-
resent ranges from two identical but separate experiments. Figure4
Effect of 4-MU on hyaluronan concentration and tissue morphol-
ogy of normal and EGF-treated organotypic keratinocyte cultures.
EGF (20 ng per mL) was present in the indicated 2.5-wk-old organ-
otypic REK cultures during the whole period, and 4-MU (0.6 mM) was
added at 1.5 wk. Two and half-wk-old cultures were fixed, embedded in
paraffin, sectioned, and double-stained for CD44 (red) and hyaluronan
(green). The yellow signal indicates colocalization of CD44 and
hyaluronan. Vertical brackets indicate the stratum corneum. Scale
bar¼10 mm (A). Hyaluronan secretion into growth medium during a 16-
h incubation at the end of the culture period was analyzed with the
ELSA assay. The error bars represent the range of two independent
experiments (B). The thickness of the vital part of the epidermis was
analyzed by morphometry. The data represent means  SE of three
separate experiments (C).
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associated with a strong inhibition of cell proliferation, to the
extent of a complete but reversible block of growth in ker-
atinocyte monolayer cultures. Considering the potential of
clinical applications, it is interesting that in the organotypic
epidermis, the hyperproliferation and hypertrophy caused
by EGF was normalized by 4-MU.
These results fit into an emerging pattern that kera-
tinocyte hyaluronan synthesis is tightly connected with
keratinocyte proliferation and epidermal thickness. Thus,
epidermal hyaluronan synthesis is specifically upregulated
by retinoic acid (Tammi et al, 1989), EGF (Pasonen-
Seppa¨nen et al, 2003), and KGF (Karvinen et al, 2003), fac-
tors known to stimulate keratinocyte proliferation and in-
crease the number of vital cell layers in the epidermis.
Furthermore, the effect of 4-MU on keratinocytes resembles
the biological activities of TGFb (Pasonen-Seppa¨nen et al,
2003), and hydrocortisone (A˚gren et al, 1995), both of which
suppress hyaluronan synthesis, keratinocyte proliferation,
and epidermal thickening. It can be concluded that 4-MU is
a novel chemical effector that confirms the association be-
tween keratinocyte hyaluronan metabolism and epidermal
proliferation. The inhibition levels, however, of hyaluronan
synthesis and proliferation rate are not correlated in abso-
lute units. Furthermore, since the mechanism of action of
4-MU is unknown, it is still possible that the two inhibitions
are independent of each other.
The inhibition of hyaluronan synthesis by 4-MU is also
associated with changes in the phenotype of single kera-
tinocytes observed in monolayer cultures. A striking effect
was inhibition of cell migration. As expected, there were
distinct cytoskeletal alterations consistent with this func-
tional transition, including the increase of stress fibers, the
reduction of dynamic lamellipodia and filopodia, and the
appearance of large, vinculin positive focal adhesions.
Vinculin is known to be downregulated in migrating kera-
tinocytes; during wound healing in human epidermis,
vinculin is absent at the leading edge (Kubler and Watt,
1993). Similar cytoskeletal and morphological alterations
are displayed by keratinocytes in which hyaluronan synthe-
sis is inhibited by transfection of a Has2 antisense gene
(Rilla et al, 2002). Furthermore, the Has2 antisense inhibition
also reduces keratinocyte migration (Rilla et al, 2002).
4-MU thus suppresses migration and proliferation, two
phenotypic features typical of epidermal activation, a re-
sponse common in injury, irritation, inflammation, transfor-
mation, and many diseases involving epidermis, psoriasis
as an example. In general, the present findings: (1) strength-
en conclusions on the phenotypic features that follow
changes in hyaluronan production, (2) indicate that 4-MU
reproduces many of the effects of specific antisense inhi-
bition of Has2 expression, (3) suggest that 4-MU is a readily
available means to suppress hyaluronan synthesis, useful in
exploring the cellular functions associated with hyaluronan,
and (4) offers a potentially useful drug for the treatment of
excessive epidermal activation.
Materials and Methods
Cell culture A newborn REK cell line (Baden and Kubilus, 1983)
was cultured in minimum essential medium, (MEM, Life Technol-
ogies, Paisley, Scotland, UK) supplemented with 5% fetal bovine
serum (FBS, HyClone, Logan, Utah), 4 mM glutamine (Sigma, St
Louis, Missouri) and 50 mg per mL streptomycin sulfate and 50 U
per mL penicillin (Sigma). Keratinocytes were passaged twice a
week at a 1:10 split ratio using 0.05% trypsin (w/v), and 0.02%
EDTA (w/v) in phosphate-buffered saline (PBS, Reagena, Kuopio,
Finland).
4-MU (sodium salt, Sigma) at 10 or 100 mM stock solution
in Hank’s balanced salt solution (HBSS, Euroclone, Milano, Italy)
was added into the culture medium to reach the concentrations
indicated.
Organotypic cultures For organotypic cultures–cells were cul-
tured on type I collagen support, and lifted to the air-liquid interface
just after having reached confluence as described previously (Pas-
onen-Seppa¨nen et al, 2001). EGF (20 ng per mL) was present in
culture medium for the whole culture period (2.5 wk), and 4-MU
(0.6 mM) was added after 1.5 weeks and kept until the end of the
experiment (i.e., for 1 wk). The secretion of hyaluronan was as-
sayed from a medium kept for 16 h with the cultures at the end of
the whole period. A part of the cultures was fixed in Histochoices
(Amresco, Solon, Ohio), and embedded in paraffin. Hematoxylin/
eosin-stained sections were morphometrically analysed to measure
epidermal thickness as described previously (Pasonen-Seppa¨nen
et al, 2003). Antigen retrieval using TUF (Monosan, Uden, the
Netherlands) was done before the double-staining for hyaluronan
and CD44 as described (Pasonen-Seppa¨nen et al, 2003).
Assay of hyaluronan A total of 80,000 cells were seeded on 24-
well plates and cultured for 24 h. Next day, a fresh medium (5%
FBS) with different concentrations of 4-MU and sometimes EGF
(20 ng per mL, Sigma) was added for 6 to 24 h before counting the
cells and harvesting the media for ELISA of hyaluronan. The sand-
wich type assay was performed as described previously (Hiltunen
et al, 2002). Briefly, maxisorp 96-well plates (Nunc, Roskilde, Den-
mark) were precoated with (non-biotinylated) HABC (hyaluronan
binding region of aggrecan and link protein), to catch hyaluronan
from the samples and standards (range 0–50 ng per mL). After
washes, biotinylated HABC was added to detect the bound
hyaluronan using horseradish peroxidase streptavidin and TMB
substrate solution (0.5% 3,30,5,50-tetramethylbenzidine in dimethyl
sulfoxide (Sigma) diluted 1:50 with 0.1 M sodium acetate, 1.5 mM
citric acid and 0.005% H2O2) for spectrophotometric quantitation.
The HABC preparations contained the hyaluronan binding re-
gions of aggrecan and link protein purified from a trypsin digest of
bovine cartilage using sequential hydroxyl apatite chromatography
and Sephacryl S-1000 gel filtration (Tammi et al, 1994). Part of the
material was biotinylated. Both HABC and bHABC were chroma-
tographed on Sephacryl S400 gel filtration under dissociative con-
ditions to remove hyaluronan.
Metabolic labeling and analysis of glycosaminoglycan syn-
thesis REK cultures were incubated for 6 h in the presence of
different concentrations of 4-MU and 20 mCi per mL of [3H]-glu-
cosamine and 100 mCi of [35S]-sulfate (Amersham, Little Chalfont,
UK). The culture media, cell trypsinization solution and cells were
collected, and analyzed for labeled glycosaminoglycans with Su-
perdex gel filtration of specific disaccharides as described previ-
ously (Tammi et al, 1998).
Molecular mass distribution of hyaluronan To analyze the size
of secreted hyaluronan, REK cultures were incubated for 6 h in the
presence of different concentrations of 4-MU and 20 mCi per mL of
[3H]-glucosamine (Amersham). The culture media were collected,
precipitated with ethanol and dissolved in 150 mM sodium ace-
tate buffer, pH 6.8 containing 0.1% CHAPS. The samples
were chromatographed on Sephacryl S-1000 (Pharmacia, Sweden)
as described previously (Karvinen et al, 2003). Two aliquots
were taken from each chromatography fraction, one incubated at
601C for 2 h with 0.5 turbidity reducing units of Streptomyces
hyaluronidase (Seikagaku Kogyo, Tokyo, Japan), and the other in
buffer only. 2% cetyl pyridinium chloride was added 1:1 to all
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samples, and the precipitates recovered with centrifugation at
13,000  g for 15 min. The content of hyaluronan in each fraction
was calculated by subtracting the radiolabel in the Streptomyces
hyaluronidase-treated samples (resistant to hyaluronidase) from
those incubated in buffer only.
Proliferation assay REK cells were seeded in 24-well culture
plates at 60,000 cells per well. Different concentrations of 4-MU
were added immediately after plating to the culture media. Cell
numbers were counted with a hemocytometer after 4 h to deter-
mine plating efficiency, and after 2–6 d to determine the prolifer-
ation rate. Cells from duplicate wells were trypsinized at each time
point. The numbers of detached cells in media were also counted.
Migration analysis The REK cells were seeded at 1  105 cells
per well in 24-well plates and grown approximately 24 h until con-
fluence. A cell-free area was introduced by scraping the monolayer
in each well crosswise with a sterile 300 mL pipette tip. The de-
tached cells were washed off with HBSS, and fresh medium with
different concentrations of 4-MU was added. The areas covered by
the cells were measured immediately, and 3, 6, and 24 h later
by phase contrast microscopy with a videocamera and quantitated by
NIH Image software (http://rsb.info.nih.gov/nih-image/). The mean
distance traveled by the cell front was calculated by converting the
pixel values into micrometers (Pienima¨ki et al, 2001).
bHABC-staining Keratinocytes were seeded at 20,000 cells per
well on 8-well chamber slides (Nalge Nunc, Naperville, Illinois)
precoated with FBS, and grown at 371C for 48 h. The slides were
washed, fixed with 2% paraformaldehyde (vol/vol), washed, perm-
eabilized with 0.3% Triton X-100 in 3% BSA, and probed with 5 mg
per mL of bHABC in 1% BSA overnight at 41C. The slides were
washed and incubated with avidin–biotin peroxidase (ABC Stand-
ard Kit, Vector Laboratories) for 1 h, and the color was developed
with 0.05% 3,30-diaminobenzine (DAB) and 0.03% H202. The nuclei
were stained with hematoxylin, and the preparations were mount-
ed in Supermount (BioGenex, San Ramon, California) and pho-
tographed using a Microphot-FXA microscope (Nikon, Tokyo,
Japan). The specificity of the staining for hyaluronan was control-
led by removing hyaluronan with Streptomyces hyaluronidase
(Seikagaku, Kogyo, Tokyo, Japan), and by pretreating the probe
with hyaluronan oligosaccharides (Tammi et al, 1998).
Immunoﬂuorescence stainings For double staining of hyalur-
onan and vinculin or CD44, keratinocytes were cultured for 24 h on
chamber slides, fixed, permeabilized and blocked as described
above, and incubated overnight at 41C with the anti-vinculin mAB
(7.1 mg per mL, clone hvin-1, Sigma) or anti-CD44 monoclonal
antibody (OX50, 1:1000, Biosource, Camarillo, California) and
bHABC (5 mg per mL) in 1% BSA. After washing, the cells were
incubated for 1 h with Texas Red-labeled anti-mouse secondary
antibody (Vector, 1:50) and fluorescein isothiocyanate-labeled avi-
din (Vector, 1:500). For the visualization of the actin filaments, the
cells were washed, fixed, permeabilized and blocked as described
above and incubated with Bodipy FL Phalloidin (4 U per mL, Mo-
lecular Probes, Eugene, Oregon) for 20 min. After washing, the
slides were mounted in Vectashield (Vector). The micrographs were
obtained with an Ultraview confocal scanner (Perkin-Elmer Life
Sciences, Wallac-LSR, Oxford, UK), on a Nikon Eclipse TE300 mi-
croscope with a 100  NA 1.3 oil immersion objective (Nikon). For
the three-dimensional imaging, a series of horizontal optical sec-
tions were captured through the cell at every 450 nm. The images
were deconvoluted using Microtome Deconvolution 7.0 software
(Vaytek, Fairfield, Iowa) and rendered with Voxblast software
(Vaytek).
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